Medigene AG Sustainability Reports

Medigene AG is a biotechnology company focused on the development of innovative immunotherapies for the treatment of cancer.

Sector: Health Care

Country: Germany

Exchange: Frankfurt Stock Exchange

ISIN: DE000A1X3W00

6 reports from 2009 to 2023

Company Profile

Medigene AG

Medigene AG is a biotechnology company focused on the development of innovative immunotherapies for the treatment of cancer.

MIC

 

Ticker

 

ISIN

 

Website

www.medigene.de

Reports

Available reports